Cargando…
Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders
The global impact imposed by the coronavirus disease 2019 (COVID-19) pandemic may be soon alleviated by the introduction and worldwide dissemination of safe and effective vaccines. This expedited timetable for development and approval of COVID-19 vaccines is an unprecedented extraordinary, concerted...
Autores principales: | Chau, Charlene Y. C., Chow, Loraine L. W., Sridhar, Siddharth, Shih, Kendrick C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936587/ https://www.ncbi.nlm.nih.gov/pubmed/33675508 http://dx.doi.org/10.1007/s40123-021-00338-1 |
Ejemplares similares
-
Considerations for Use of Immune Checkpoint Inhibitors in Cancer Therapy for Patients with Co-Existing Thyroid Eye Disease
por: Chau, Charlene Y. C., et al.
Publicado: (2020) -
Does the COVID-19 Pandemic Spell the End for the Direct Ophthalmoscope?
por: Shih, Kendrick C., et al.
Publicado: (2020) -
A Proposed Framework for Machine Learning-Aided Triage in Public Specialty Ophthalmology Clinics in Hong Kong
por: Li, Yalsin Yik Sum, et al.
Publicado: (2021) -
Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders
por: Moreker, Mayur R
Publicado: (2020) -
Recent Advances in Ophthalmology
por: Wright, R. E.
Publicado: (1935)